Brief: Yumanity Reports Partial Clinical Hold By U.S. FDA On Multidose Clinical Trials For YTX-7739

Kineta

19/01/2022 12:32

Jan 19 (Reuters) - Yumanity Therapeutics Inc  YMTX.O :
    * YUMANITY REPORTS PARTIAL CLINICAL HOLD BY U.S. FDA ON
MULTIDOSE
CLINICAL TRIALS FOR YTX-7739
    * YUMANITY REPORTS PARTIAL CLINICAL HOLD BY U.S. FDA ON
MULTIDOSE
CLINICAL TRIALS FOR YTX-7739
    * YUMANITY THERAPEUTICS INC - ANTICIPATES WORKING CLOSELY
WITH FDA
TO ADEQUATELY ADDRESS THEIR CONCERNS
    * YUMANITY THERAPEUTICS INC - EXPECTS TO RECEIVE ADDITIONAL
DETAIL
FROM FDA WITHIN NEXT 30 DAYS ON MULTIDOSE TRIALS FOR YTX-7739
    * YUMANITY THERAPEUTICS - PARTIAL CLINICAL HOLD SUSPENDS
INITIATION OF MULTIPLE DOSE CLINICAL TRIALS IN U.S. UNTIL FDA'S
QUESTIONS HAVE BEEN ADDRESSED
    * YUMANITY THERAPEUTICS INC - FDA HAS NOT HALTED ALL
CLINICAL
PROGRAMMING AND IS PERMITTING CO'S PLANNED SINGLE DOSE CLINICAL
TRIAL TO PROCEED

Source text for Eikon:  ID:nGNX1JwFqw 
Further company coverage:  YMTX.O